According to current evidence, elevation of cardiac injury biomarkers, such as troponin and hs-TnI, CK-MB, myoglobin and NT-proBNP, is associated with COVID-19 severity and mortality [87,88,92]. This evidence concerns the gene MB and COVID-19.